Health tech company Waltz Health will merge with Eversana with the goal of shaking up access to prescription drugs. The deal will bring together Waltz's proprietary drug marketplaces and ...

Shares of Eton Pharmaceuticals rose after the company acquired U.S. commercialization rights to a treatment for proliferating infantile hemangioma, a form of non-cancerous tumor found in newborns.

HEMANGEOL® is the only FDA-approved treatment for infantile hemangiomaHEMANGEOL will be commercialized by Eton beginning May 1stHEMANGEOL will be ...

Asahi Kasei acquires Aicuris for €780M ($920M), adding anti-infective assets to its transplant and nephrology specialty ...

Combined company offers next-generation commercialization model that directly connects life sciences to payers and patients to accelerate access, improve affordability and transform drug value across ...

TEL AVIV, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal ...

EVERSANA and Waltz Health have merged to create a new healthcare platform, with the goal of redefining pharmaceutical commercialization and patient access. The merger combines EVERSANA’s global ...

Pharma leaders cite regulatory change as one of the top trends likely to impact their corporate strategies in 2026. While staffing and funding cuts at HHS may slightly slow down drug approvals, new ...

REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients ...

HUNTINGTON, N.Y., Dec. 9, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics for inflammation-driven conditions, today ...

I have been involved in launching medtech products across nearly 30 markets. These are the lessons that only became clear ...

Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce ...